IL-17 Drug Phase 3 Success for Junshi’s Psoriasis Med
Junshi Biosciences reports a major phase 3 win for its new il-17 drug targeting psoriasis, signaling a significant advancement and a planned push into the China market.
clinical trial
Read More
PD-L1xVEGF Bispecific: 1st Global Data from BioNTech/BMS
BioNTech and BMS reveal promising first-in-human global data for their novel PD-L1xVEGF bispecific antibody, showing potential in treating advanced solid tumors.
ph. 3 win: Regeneron’s 2 Allergy Antibodies Succeed
Regeneron announces a major ph. 3 win for its new antibody treatment, showing significant success in reducing symptoms for both cat and seasonal pollen allergies.
Medtronic’s Hugo Robot Sees 100% Success in Hernia Trial
Medtronic’s Hugo robot has logged a major success in its latest clinical trial for hernia repair, demonstrating safety and efficacy in all procedures performed.